Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a PowerPoint slide presentation developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Adolescents are disproportionately affected by HIV, accounting for approximately 1 in 5 new HIV infection in the United States. The expanded options for pre-exposure prophylaxis (PrEP) in adolescents provides clinicians with additional, effective tools to further reduce the risk of HIV transmission in this group. Once diagnosed, youth with HIV are the least likely out of any age group to be linked to care and achieve viral suppression once on ART.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Talking Hemophilia A is a roundtable discussion continuing education activity designed to inform and guide on integrating novel therapies into hemophilia A treatment paradigms.

The expert faculty presenters will provide an overview of existing approaches and their limitations and how new and emerging therapies can be used to address unmet needs. The activity will be supported by downloadable, supplemental slides that have the key discussion and teaching points.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Through patient cases, this slide kit shows the key considerations to manage patients with PAH. Case 1 will show the patient with underlying cardiac defects and repair history and lifelong management in multidisciplinary specialty centers with expertise in pulmonary arterial hypertension - congenital heart disease (PAH-CHD). Case 2 will review the initial management of right heart failure in pulmonary hypertension (PH). Case 2 will be continued to show intensive care management.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. The Lecture Library offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/posttest and evaluation.

Continue to visit the Lecture Library series throughout 2023 to view updates from new publications and conference updates. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Activity Summary:
Despite advances in the initial treatment strategies of multiple myeloma, many patients will experience an early relapse. The further management of such patients can be challenging given the various options and complex patient- and disease-related factors.

Conversations and Cases in Multiple Myeloma is a roundtable discussion activity designed to inform and guide on integrating recent progress in the management of early relapse. The expert faculty will discuss different cases with early relapse and provide guidance on safely using approved and emerging therapy to improve outcomes. The activity will be supported by downloadable slides that have key discussion and teaching points.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a PowerPoint slide presentation developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

One key strategy for ending the HIV epidemic in the United States is the rapid and large scale-up of pre-exposure prophylaxis (PrEP) provision by clinicians providing health care to HIV-uninfected persons at risk for HIV acquisition. Current recommendations encourage informing all sexually active adults and adolescents about PrEP, as well as offering PrEP to those at substantial risk of HIV acquisition. This activity will discuss the impact of PrEP on ending the HIV epidemic, benefits and limitations of new and future PrEP options, and strategies to improve sustainable implementation of PrEP.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented from the 2023 Conference on Retroviruses and Opportunistic Infections.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from October through December of 2022 will discuss the most clinically relevant information regarding Long-Acting ART, General ART Studies, Cancer and Coinfections and Mpox and HIV.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of accredited continuing education enduring videos will provide brief commentary spotlighting hot topics in myelodysplastic syndromes (MDS) presented at the 2022 American Society for Hematology (ASH) Annual Meeting from New Orleans, Louisiana.

Activity Summary:
Patient Perspectives in HIV: A CE Podcast Series is an accredited continuing education series of podcasts as downloadable audio files (MP3). These podcasts will be recorded and made available throughout the year.

In this series of podcasts, the content faculty and one of their patients will discuss considerations and challenges in the prevention and treatment of HIV. Topics covered will include patient concerns, benefits and risks of antiretroviral therapy, and how patients have handled challenges in their HIV management.

Activity Summary:
One of the key targets towards ending the HIV epidemic in the United States is prescribing pre-exposure prophylaxis (PrEP). It provides safe and robust protection against HIV infection in a diversity of populations at risk. Current recommendations encourage informing all sexually active adults and adolescents about PrEP, as well as offering PrEP to those at substantial risk of HIV acquisition.

Learning from Success will highlight lessons learned from an innovative HIV clinic on their successful strategies for PrEP engagement as well as providing oral and long-term injectable PrEP to those at risk for HIV.

Activity Summary:
Conversations and Updates in Gastric/GEJ Cancer is a roundtable discussion designed to inform and guide on the latest breakthroughs to improve patient outcomes.

Through patient cases and scenarios, the expert faculty presenters will illustrate the integration of new evidence and biomarkers to safely treat and manage diverse patients with gastric/GEJ cancer. The activity will be supported by downloadable slides that have the key discussion/teaching points.

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings.

This activity provides an expert discussion around the updated guidelines from the European Society of Cardiology (ESC) and European Respiratory Society (ERS) as well as research presented at both ERS and CHEST 2022. These discussions provide the latest evidence for the care of patients with pulmonary hypertension based on data released from these conferences. Additionally, this activity also discusses the array of registry databases, what information has been yielded about the demographic factors, treatment, and survival of patients, as well as their limitations, which provides real-world evidence that informs clinical practice and health policy.

Activity Summary:
The Talking Post-Transplant Acute Myeloid Leukemia (AML) webcast series will provide recent updates to improve outcomes in post-transplantation relapse in AML.

This webcast series, led by expert faculty, will provide guidance and practical strategies to safely implement recent progress in addressing post-transplantation relapse in AML. Through patient cases and scenarios, faculty presenters will guide the integration of new evidence into clinical treatment paradigms of AML in the post-transplantation setting. The activity will be supported by downloadable slides that have the key discussion/teaching points.

*Healthcare providers may only claim for the participation of one (1) enduring archive activity.

Activity Summary:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease (PH-ILD). Slides are developed and updated throughout the year by leading pulmonology expert physicians. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

Patients with PH-ILD face a dismal prognosis and are associated with reduced exercise capacity, greater need for supplemental oxygen, and a decreased quality of life. In recent years, there have been several advances in the treatment and management of PH-ILD. This slide kit will use three case scenarios to illustrate best-practice approaches to accurately diagnose PH-ILD and differentiate it from group 1 pulmonary arterial hypertension (PAH). It will also provide guidance on integrating recent progress in the treatment of PH-ILD and on the safe and effective use of approved and emerging therapy.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a progressive and often fatal illness presenting with nonspecific symptoms of dyspnea, lower extremity edema, and exercise intolerance. Most of the available drugs and FDA‐approved therapies for treating pulmonary hypertension attempt to overcome the imbalance between vasoactive and vasodilator mediators and restore the endothelial cell function. New research has identified molecular targets that mediate vasodilation, anti‐inflammatory, and antifibrotic changes within the pulmonary vasculature. This on-demand presentation will provide an updated overview of new therapeutic approaches under investigation for the treatment of PAH, as well as strategies to optimize outcomes for patients with PAH.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented from HIV Drug Therapy, Glasgow 2022.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a video of ‘what you need to know’ from data presented during IDWeek 2022.

Activity Summary:
Talking COPD is a webcast series that highlights the very latest clinical data in chronic obstructive pulmonary disease (COPD). Slides are developed and presented by leading COPD expert physicians and further reviewed and approved by the planning committee. Talking COPD can be accessed for AMA, ANCC or ACPE credit.

COPD is a complex and heterogeneous disease, associated with significant medical, economic, and societal burden, which is predicted to increase over the coming decades. COPD imposes significant impact beyond the lungs, including on quality of life, health status, daily activities, physical activity, and sleep, as well as comorbid anxiety and depression. Given the increasing recognition of, and importance attributed to, patients’ and caregivers’ views and preferences on disease management, it is important to identify and understand their perception of COPD and the individualized impact on their lives. This understanding can help guide clinical decision-making and improve outcomes for patients with COPD.

In this on-demand webcast the learner will go through a complete virtual patient tour starting at the time of symptoms of COPD through the burden of the disease, diagnosis, evaluation, and individualized, clinically supported, guideline-based management, drawing from the GOLD Report for COPD.

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American College of Chest Physicians Annual Meeting in Nashville, Tennessee, October 16-19, 2022, through a series of two ‘what you need to know in 5-minutes’ videos.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from July through September of 2022 will discuss the most clinically relevant information regarding HIV Cure and Treatment, ART and Pregnancy and Coinfections and Non-ART.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Currently, therapies for treating pulmonary hypertension have been used alone and in combination to demonstrate improvements in quality of life and hemodynamic parameters as well as in slowing disease progression; however, beneficial effects on survival are limited. None offer a cure against PAH nor directly address the underlying cellular proliferation that leads to increased pulmonary arterial pressure, and the median survival rate remains at 61% at five years after diagnosis. Extensive research efforts have led to the emergence of innovative therapeutic approaches in PAH. This on-demand webcast focuses on several important aspects of PAH management, including a discussion of the challenges diagnosing and treating patients, clinical trial data on emerging therapeutics for the management of PAH, and a review of strategies to optimize outcomes for patients with PAH.

Activity Summary:
The expansion of PrEP provision could help to stem the number of new HIV infections globally. Studies are underway to optimize their tolerability with novel regimens and methods of delivery in the hope that persons with diverse patterns of sexual risk and personal preferences will find chemoprophylaxis to be acceptable and beneficial. However, in addition to antiretroviral regimen tolerability and efficacy, there are clearly social and behavioral factors that impact adherence to medications and associated clinical monitoring, which remain suboptimal in some populations; developing interventions to support adherence to chemoprophylaxis will be essential.

In this episode of Conversations in HIV, the faculty engages in a thought-provoking discussion identifying strategies to facilitate successful and sustainable implementation of PrEP for specific patients to include a MSM and IDU at Risk for HIV, Cisgender Woman Without HIV and MSM with Multiple Comorbidities.

Activity Summary:
This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies for cisgender women such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.

Activity Summary:
The Talking Multiple Myeloma webcast archive will highlight recent advances in the initial management of multiple myeloma (MM).

Through patient cases and scenarios, the expert faculty presenters will discuss practice-changing updates in the initial management of MM, strategies to improve patient outcomes and prevent/manage adverse events as well as guide the integration of new evidence into clinical treatment paradigms.

Activity Summary:
With the recent approval of atezolizumab and osimertinib, and several ongoing trials, it has become clear that immunotherapy and targeted approaches are gaining ground in the adjuvant and neoadjuvant setting of early-stage non-small cell lung cancer (NSCLC). Considering the continual updates from clinical trials in this space, it is pivotal that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This activity will highlight the practice-changing updates in adjuvant and neoadjuvant approaches in early-stage NSCLC, to enable safe and effective implementation into clinical practice through expert-guided discussions with Drs. Julie Brahmer, Jamie Chaft and Stephen Liu.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Recent progress in pulmonary arterial hypertension (PAH) is based on new strategies for combination therapy and the escalation of treatments to improve the significant morbidity and mortality associated with this disease. This on-demand presentation is a case-based discussion on the importance of a proper workup to reach the correct diagnosis and monitoring patients to determine when and how to optimally alter their PAH therapy.

Activity Summary:
Combining tyrosine kinase inhibitor and immunotherapy agents has shown considerable promise in Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL). Although this approach can provide a chemotherapy-free and transplantation-sparing alternative, it is imperative that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This certified AMA activity will highlight the practice-changing updates in the frontline treatment of Ph+ ALL and provide guidance on effective implementation of new evidence through expert-guided discussions and interactive case scenarios.

Activity Summary:
Currently the South is the epicenter of the HIV epidemic in the United States. It experiences the greatest burden of HIV and deaths, and improvement is needed in providing HIV prevention services and care. Closing these gaps is essential to the health of people in the region and meeting the national goal of ending the HIV epidemic.

These accredited continuing education webcasts will be presented by HIV specialists who practice in the Southern United States. Geographically appropriate topics and practical strategies such as Adolescence, Sexual and Gender Minorities and Cisgender Women populations will be discussed.

Activity Summary:

This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies within sexual and gender minorities such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.